Article from Townsend Letter:
Hospital-Based Intravenous Vitamin C Treatment for Coronavirus and Related Illnesses
by Andrew W. Saul and Atsuo Yanagisawa, MD, PhD
Originally published in Orthomolecular Medicine News Service, Feb 2, 2020 available for free subscription
No matter which hospital a coronavirus patient may seek help from, the question is, will they be able to leave walking out the front door, or end up being wheeled out the basement backdoor? Prompt administration of intravenous vitamin C, in high doses, can make the difference.
Abundant clinical evidence confirms vitamin C’s effectiveness when used in sufficient quantity.1 Physicians have demonstrated the powerful antiviral action of vitamin C for decades.2
Specific Instructions for Intravenous Vitamin C
The Japanese College of Intravenous Therapy (JCIT) recommends intravenous vitamin C (IVC) 12.5/25g (12,500 – 25,000 mg) for acute viral infections (influenza, herpes zoster, common cold, rubella, mumps, etc.) and virus mimetic infections (idiopathic sudden hearing loss, Bell’s palsy). In adults, IVC 12.5 g is given for early stage illness with mild symptoms, and IVC 25 g for moderate to severe symptoms. IVC is usually administered once or twice a day for two-to-five continuous days, along with or without general treatments for viral infections.
| IVC 12.5 g cocktail | |
| 50% Vitamin C 25 mL (12.5g) | |
| 0.5M Magnesium sulfate 10mL | |
| Add Vitamin B complex | |
| Drip for 30-40 min |
| IVC 25 g cocktail | |
| Sterile water 250 mL | |
| 50% Vitamin C 50 mL (25g) | |
| 0.5M Magnesium sulfate 20 mL | |
| Add Vitamin B complex | |
| Drip for 40-60 min |
Patients with acute viral infections show a depletion of vitamin C and increasing free radicals and cellular dysfunction. Such patients should be treated with vitamin C, oral or IV, for neutralizing free radicals throughout the body and inside cells, maintaining physiological functions, and enhancing natural healing. If patients progress to sepsis, vitamin C should be added intravenously as soon as possible along with conventional therapy for sepsis.
Fred Hui, MD believes that administering vitamin C intravenously is a treatment worth trying. And he’d like to see people admitted to hospital for the pneumonia-like virus treated with the vitamin intravenously while also receiving the usual drugs for SARS. “I appeal to hospitals to try this for people who already have SARS,” says Hui. Members of the public would also do well to build up their levels of vitamin C, he says, adding that there is nothing to lose in trying it. “This is one of the most harmless substances there is,” Hui states. “There used to be concern about kidney stones, but that was theoretical. It was never borne out in an actual case.” Hui says he has found intravenous vitamin C effective in his medical practice with patients who have viral illnesses.3
Additional administration details are readily obtained from a free download of the complete Riordan Clinic Intravenous Vitamin C Protocol.4 Although initially prepared for cancer patients, the protocol has found widespread application for many other diseases, particularly viral illnesses.
Research and experience has shown that a therapeutic goal of reaching a peak-plasma concentration of ~20 mM (350- 400 mg/dL) is most efficacious. (No increased toxicity for posoxidant [sic] IVC plasma vitamin C levels up to 780 mg/dL has been observed.) . . . [T]he administering physician begins with a series of three consecutive IVC infusions at the 15, 25, and 50 gram dosages followed by post IVC plasma vitamin C levels in order to determine the oxidative burden for that patient so that subsequent IVCs can be optimally dosed.
Pages 16-18 of the Riordan protocol present IVC administration instructions.
There are four pages of supporting references.
“Given the rapid rate of success of intravenous vitamin C in viral diseases, I strongly believe it would be my first recommendation in the management of corona virus infections.”
(Victor A. Marcial-Vega, MD)
Puerto Rico
“It is of great importance for all doctors to be informed about intravenous vitamin C. When a patient is already in hospital severely ill, this would be the best solution to help save her or his life.”
(Karin Munsterhjelm, MD)
Finland
Winning the Hospital Game
When faced with hospitalization, the most powerful person in the entire hospital system is the patient. However, in most cases, the system works on the assumption that the patient will not claim that power. If on your way in you signed the hospital’s legal consent form, you can unsign it. You can revoke your permission. Just because somebody has permission to do one thing doesn’t mean that they have the permission to do everything. There’s no such thing as a situation that you cannot reverse. You can change your mind about your own personal healthcare. It concerns your very life. The rights of the patient override the rules of any institution.
If the patient doesn’t know that, or if they’re not conscious, or if they just don’t have the moxie to do it, the next most powerful person is the spouse. The spouse has enormous influence and can do almost as much as the patient. If the patient is incapacitated, the spouse can, and must, do all the more. If there is no spouse present, the next most powerful people in the system are the children of the patient.
When you go to the hospital, bring along a big red pen, and cross out anything that you don’t like in the hospital’s permission form. And before you sign it, add anything you want. Write out “I want intravenous vitamin C, 25 grams per day, until I state otherwise.” And should they say, “We’re not going to admit you,” you reply, “Please put it in writing that you refuse to admit me.” What do you think their lawyers are going to do with that? They have to admit you. It’s a game, and you can win it. But you can’t win it if you don’t know the rules. And basically, they don’t tell you the rules.
This is deadly serious. Medical mistakes are now the third leading cause of death in the US. Yes, medical errors kill over 400,000 Americans every year. That’s 1,100 each day, every day.5
“If a family member of mine died due to coronavirus infection, after a doctor refused to use intravenous vitamin C, I would challenge his or her treatment in a court of law. I would win.”
(Kenneth Walker, MD, surgeon)
There are mistakes of commission and mistakes of omission. Failure to provide intravenous vitamin C is, literally, a grave omission. Do not allow yourself or your loved ones to be deprived of a simple, easy to prepare and administer IV of vitamin C.
It Can Be Done
Vitamin IVs can be arranged in virtually any hospital, anywhere in the world. Attorney and cardiologist Thomas E. Levy’s very relevant presentation is free access.6,7
Both the letter and the intent of new USA legislation now make this easier for you.
The new federal Right to Try Act provides patients suffering from life-threatening diseases or conditions the right to use investigational drugs… It amends the Food, Drug, and Cosmetic Act to exempt investigational drugs provided to patients who have exhausted approved treatment options and are unable to participate in a clinical trial involving the drug. Advocates of right to try laws have sought to accelerate access to new drugs for terminally ill patients who are running out of options. Arguably, the law does not represent a radical change in this and several other states, however, because in 2016, California had already joined the majority of other states in adopting a law enabling physicians to help terminally ill patients pursue investigational therapies, without fear of Medical Board or state civil or criminal liability. . . The new Right to Try law should give physicians, as well as drug manufacturers, some added comfort about FDA enforcement in these cases.8
Therefore, in regards to intravenous vitamin C, do not accept stories that “the hospital can’t” or “the doctor can’t” or that “the state won’t allow it.” If you hear any of this malarkey, please send the Orthomolecular Medicine News Service the text of the policy or the law that says so. In the meantime, take the reins and get vitamin C in the veins.
References:
Author Bios:
Andrew W. Saulis Editor-in-Chief of the peer-reviewed Orthomolecular Medicine News Service. He is also a member of the board of the Japanese College of Intravenous Therapy, and of the Advisory Board to the International Intravenous Vitamin C China Epidemic Medical Support Team. He was on the faculty of the State University of New York for nine years, and taught nutrition, health science and cell biology at the college level. Saul has studied in Africa and Australia, holds three state certificates in science education, and has twice won New York Empire State Fellowships for teaching. A list of over 200 of his publications, with online links to most of them, is at http://www.doctoryourself.com/publications.html. Andrew Saul was inducted into the Orthomolecular Medicine Hall of Fame in 2013. He has been honored with the Riordan Clinic’s Pearlmaker Award, Citizens for Health Outstanding Health Freedom Activist Award, and was named one of seven natural health pioneers by Psychology Today. He is the author, coauthor or editor of 25 books, four written with Abram Hoffer, MD. Andrew Saul is featured in the movies FOODMATTERS and THAT VITAMIN MOVIE. He is on Facebook and MeWe as “themegavitaminman.” His free-access, peer-reviewed website is www.doctoryourself.com.
Atsuo Yanagisawa, MD, PhD,graduated from the Kyorin University School of Medicine in 1976, and completed his graduate work in 1980 from the Kyorin University Graduate School of Medicine in Tokyo, Japan. Dr. Yanagisawa served as Professor in Clinical Medicine at the Kyorin University School of Health Sciences, and concurrently as Professor in Clinical Cardiology at Kyorin University Hospital until 2008.
Dr Yanagisawa has served as the Director of The International Education Center for Integrative Medicine in Tokyo, Japan, since 2008. He has introduced many well-known teachers from North America in Japan, including Burt Berkson, Michael Janson, John Hoffer and Steve Hickey. He is a fellow of the American College for Advancement in Medicine, and board certified in chelation therapy. In 2004, he established the SPIC Salon Medical Clinic, which combines IV treatments in a spa setting. The Japanese College of Intravenous Therapy was founded in 2007, with Dr Yanagisawa as President. The College has grown to almost 400 doctors in 200 clinics in every region of Japan, Dr Yanagisawa presented at the 2nd IV C Symposium in Wichita, Kansas, in October 2010 and launched the International College of IV Therapy, which held their first conference, also in October 2010, bringing together experts in the field from Japan and around the world.
Dr Yanagisawa is the author of 140 scientific papers in English and Japanese and has published several books in cardiology, chelation, nutrition, coaching, and IV vitamin C for cancer. He honours his mentors, especially Dr Hinohara and Mr Daisuke Shibata.
Dr Yanagisawa’s significant contribution as a pioneer in Intravenous Therapy in Japan has earned him a place in the Orthomolecular Medicine Hall of Fame.
Consult your doctor before using any of the treatments mentioned in this article.
Reprinted with permission from the May 2020 Townsend Letter, Andrew W. Saul and Atsuo Yanagisawa, MD, PhD
Learn how you can benefit from more Townsend Letter articles.